We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$12.5M
Cap. Flow
-$6.4M
Cap. Flow %
-5.31%
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
81
Closed
24

Top Buys

Rank Stock Value
1
PRLB icon
Protolabs
PRLB
+$145K
2
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$111K
3
ATRC icon
AtriCure
ATRC
+$87.8K
4
TNDM icon
Tandem Diabetes Care
TNDM
+$78.8K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$67.8K

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$2.16M
2
KRYS icon
Krystal Biotech
KRYS
+$2.02M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$637K
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$584K
5
HALO icon
Halozyme
HALO
+$430K

Sector Composition

Rank Sector Weight
1 Healthcare 7.9%
2 Financials 4.48%
3 Technology 3.39%
4 Consumer Discretionary 2.75%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RH icon
501
RH
RH
$3.33B
$1.06K ﹤0.01%
4
– –
FDRR icon
502
Fidelity Dividend ETF for Rising Rates
FDRR
$730M
$1.04K ﹤0.01%
26
– –
ALDX icon
503
Aldeyra Therapeutics
ALDX
$97.1M
$1.03K ﹤0.01%
155
– –
MHH icon
504
Mastech Digital
MHH
$95.4M
$1.03K ﹤0.01%
115
– –
WEN icon
505
Wendy's
WEN
$1.46B
$1.01K ﹤0.01%
49
– –
PTON icon
506
Peloton Interactive
PTON
$2.85B
$960 ﹤0.01%
190
– –
NKLA
507
DELISTED
Nikola Corporation Common Stock
NKLA
$942 ﹤0.01%
20
– –
NTLA icon
508
Intellia Therapeutics
NTLA
$1.51B
$885 ﹤0.01%
28
– –
VTR icon
509
Ventas
VTR
$47.5B
$863 ﹤0.01%
20
– –
BX icon
510
Blackstone
BX
$104B
$857 ﹤0.01%
8
– –
COHN icon
511
Cohen & Co
COHN
$33.8M
$845 ﹤0.01%
130
+4
+3% +$29
APTO
512
DELISTED
Aptose Biosciences, Inc.
APTO
$840 ﹤0.01%
10
– –
CHWY icon
513
Chewy
CHWY
$9.54B
$822 ﹤0.01%
45
– –
OXY icon
514
Occidental Petroleum
OXY
$55.7B
$790 ﹤0.01%
12
– –
BCX icon
515
BlackRock Resources & Commodities Strategy Trust
BCX
$896M
$787 ﹤0.01%
85
+1
+1% +$9
BYND icon
516
Beyond Meat
BYND
$274M
$779 ﹤0.01%
81
– –
OPRX icon
517
OptimizeRx
OPRX
$120M
$778 ﹤0.01%
100
– –
IYM icon
518
iShares US Basic Materials ETF
IYM
$1.13B
$758 ﹤0.01%
+6
New +$793
GEN icon
519
Gen Digital
GEN
$16.5B
$737 ﹤0.01%
42
+1
+2% +$20
ANNX icon
520
Annexon
ANNX
$796M
$708 ﹤0.01%
300
– –
BLUE
521
DELISTED
bluebird bio
BLUE
$699 ﹤0.01%
12
– –
AVGR
522
DELISTED
Avinger, Inc. Common Stock
AVGR
$685 ﹤0.01%
127
– –
ISTB icon
523
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
$649 ﹤0.01%
14
– –
SWBI icon
524
Smith & Wesson
SWBI
$649M
$648 ﹤0.01%
50
– –
KEP icon
525
Korea Electric Power
KEP
$14.6B
$644 ﹤0.01%
100
– –
19 20
21
22 23

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return

HighMark Wealth Management's Q3 2023 Portfolio in Review

As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.

  • HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
  • HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
  • HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
  • HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
  • HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
  • HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.

Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.